| Vertex to Present at the Piper Jaffray Healthcare Conference on December 1 | |
| | |
|
BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will participate in a fireside chat at the Piper Jaffray Healthcare Conference in New York on Tuesday, December 1 at 11:00 a.m. ET. Management’s remarks will be available live through Vertex’s website at www.vrtx.com in the “Investors” section under the “Events and Presentations” page. A replay of the conference webcast will be archived on the company’s website. About Vertex Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For five years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com. (VRTX-WEB) View source version on businesswire.com: http://www.businesswire.com/news/home/20151123006203/en/
|
|
| |
ProfilIndicateurs de MarchéVALEUR : Projets & res.Communiqués de PresseRapport annuelRISQUE : Profile actifsContactez la cie |
Vertex Pharma est une société basée aux Etats-Unis D'Amerique. Vertex Pharma est cotée aux Etats-Unis D'Amerique. Sa capitalisation boursière aujourd'hui est 99,9 milliards US$ (92,8 milliards €). La valeur de son action a atteint son plus bas niveau récent le 12 mars 2004 à 10,00 US$, et son plus haut niveau récent le 03 mai 2024 à 401,08 US$. Vertex Pharma possède 249 070 000 actions en circulation. |